BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Department of Pharmacology: David James Lecture 2026\, Prof Lotte 
 Bjerre Knudsen - Professor Lotte Bjerre Knudsen\, Head of IDEA and Chief S
 cientific Advisor at Novo Nordisk
DTSTART:20260116T130000Z
DTEND:20260116T140000Z
UID:TALK241063@talks.cam.ac.uk
CONTACT:116482
DESCRIPTION:Department of Pharmacology: David James Lecture 2026\n\nSpeake
 r: Professor Lotte Bjerre Knudsen\, Head of IDEA and Chief Scientific Advi
 sor at Novo Nordisk\n\nTitle: GLP-1: the medicines\, the biology\, and the
  learnings\n\nDate and Time: Friday 16 January\, 13:00. Reception to follo
 w at 14:00\n\nLocation: Department of Biochemistry\, Jean Thomas Lecture T
 heatre\n\nIn person only. Registration required: https://www.eventbrite.co
 m/e/david-james-lecture-2026-professor-lotte-bjerre-knudsen-tickets-197026
 0479131\n\nBiography: Lotte Bjerre Knudsen is a Danish national\, born in 
 1964 in a small town near Copenhagen. Lotte holds a degree in biotechnolog
 y from the Technical University of Denmark\, and a Doctoral Degree in Scie
 ntific Medicine from the University of Copenhagen\, and she is an Adjunct 
 Professor of Translational Medicine for Aahus University. Lotte has an H-i
 ndex of 63\, is an inventor on numerous patents\, and is most prominently 
 a recipient of the Paul Langerhans Award\, the Science Mani Bhaumik Breakt
 hrough of the Year Award\, the Lasker-DeBakey Clinical Research Award and 
 the Breakthrough Prize of Life Sciences.\n\nLotte Bjerre Knudsen is the Ch
 ief Scientific Advisor for R&D at Novo Nordisk. She heads up the team IDEA
  (Innovation & Data Experimentation Advancement) that focuses entirely on 
 human data driven insights to inform drug discovery. Lotte has held her cu
 rrent role since 2022\, after spending 2021 in Oxford. She is a long-time 
 employee of Novo Nordisk\, since 1989. Lotte is a co-inventor of liragluti
 de and has led all biology research programs for liraglutide and semagluti
 de from diabetes to obesity\, cardiovascular\, liver\, kidney and Alzheime
 r’s Disease. She has been part of representing Novo Nordisk in five FDA 
 Advisory committees\n\nLotte has received numerous awards. Most recently\,
  she was a recipient of the 2025 Breakthrough Prize in Life Sciences\, the
  Paul Langerhans Award from the German Diabetes Association\, the STAT Bio
 medical Innovation Award\, and a co-recipient of the American Association 
 for the Advancement of Science Mani Bhaumik Breakthrough of the Year Award
 .\n\nThe David James Lectures are the Department of Pharmacology’s flags
 hip lecture series. Named after Dr David James\, a former Departmental Adm
 inistrator who left behind a legacy to the Department to provide scholarsh
 ips to gifted postgraduates\, this series aims to draw superstar research 
 speakers to Cambridge\, promoting collaboration and sparking inspiration. 
 A list of previous speakers can be found here: https://www.phar.cam.ac.uk/
 david-james-annual-seminar-series. \n
LOCATION:Department of Biochemistry\, Jean Thomas Lecture Theatre
END:VEVENT
END:VCALENDAR